Literature DB >> 12420070

Dyshormonal disorders in gout: experimental and clinical studies.

I V Mukhin1, G A Ignatenko, V Yu Nikolenko.   

Abstract

A total of 107 patients with primary gout were examined. The pituitary-gonadal system is imbalanced in male patients with gout, which manifests by hyperproduction of progesterone and suppressed production of testosterone and estradiol. These changes are more pronounced in patients with chronic arthritis and proteinuric nephropathy. Similar dyshormonal changes are experimentally simulated in rats by induction of purine metabolism disorders. Exogenous injection of androgens in experimental hyperuricemia led to normalization of purine metabolism and hormonal homeostasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420070     DOI: 10.1023/a:1019826107916

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  4 in total

1.  Changes in Sex Hormones After Laparoscopic Sleeve Gastrectomy in Chinese Obese Men: a 12-Month Follow-Up.

Authors:  Cuiling Zhu; Yi Zhang; Ling Zhang; Jingyang Gao; Fangyun Mei; Bing Zhu; Liesheng Lu; Donglei Zhou; Shen Qu
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

2.  Persistent normalization of serum levels of uric acid in a gouty patient after administration of cyproterone acetate.

Authors:  C Palazzi; S D'Angelo; E Pennese; I Olivieri
Journal:  Rheumatol Int       Date:  2008-11-12       Impact factor: 2.631

3.  Influence of androgen deprivation therapy on serum urate levels in patients with prostate cancer: A retrospective observational study.

Authors:  Jun Won Park; Jae Hyun Lee; Hyon Joung Cho; You-Jung Ha; Eun Ha Kang; Kichul Shin; Seok-Soo Byun; Eun Young Lee; Yeong Wook Song; Yun Jong Lee
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

4.  Association between Sex Hormone and Blood Uric Acid in Male Patients with Type 2 Diabetes.

Authors:  Wen Cao; Ren-Dong Zheng; Shu-Hang Xu; Yao-Fu Fan; Hong-Ping Sun; Chao Liu
Journal:  Int J Endocrinol       Date:  2017-10-03       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.